9 - 10 July 2020

MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases

New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases scheduled to be held on 9th -10th July 2020 will provide valuable and necessary platform for uplifting knowledge at the forefront of drug analysis. Over the course of the conference, internationally-renowned speakers can describe how their analysis journeys have developed the response towards up to date challenges. The attending specialists and trade partners will offer an incredible networking expertise.

 

This conference will gather scientists, researchers, entrepreneurs, academicians, medical officers, CEO’s, CSO’s and technologists from everywhere around the globe to discuss on the newest scientific advances within the field of rare diseases & orphan drugs that facilitate to form current and future challenges in drug analysis.

WHAT TO EXPECT
Who should attend?
  • C-Level Executives, VPs/Directors, Heads, Professors, Associate professors (Biology, Biochemistry), Researchers from Pharma/Therapeutics / Biopharma and Universities- Rare diseases department
  • Patient Advocacy groups
Why attend Virtual?
  • 100+ C-level executives, Directors/VPs, Heads experts working on rare disease attending the event
  • Participate in constructive discussion with leading industry experts and decision-makers from pharmaceutical manufacturers who will tackle the most important issues in Rare disease diagnosis.
  • Best opportunity to showcase your work and research in front of industry leaders.
  • Develop your skills by learning new competencies and acquire knowledge from pioneers all around the world.
CONFERENCE SPEAKERS
Speakers
Patricia Weltin

Patricia Weltin

CEO/Founder
Beyond the Diagnosis

Patricia Weltin

CEO/Founder
Beyond the Diagnosis
Gregory R Stewart

Gregory R Stewart

PhD- Senior Vice President, Vector Delivery and Optimization
Axovant Sciences

Gregory R Stewart

PhD- Senior Vice President, Vector Delivery and Optimization
Axovant Sciences
Karen Cashmere

Karen Cashmere

Chief Commercial Officer
ZyVersa Therapeutics, Inc.

Karen Cashmere

Chief Commercial Officer
ZyVersa Therapeutics, Inc.
Evelina Paberze

Evelina Paberze

Chief Operating Officer
HRA Pharma Rare Diseases

Evelina Paberze

Chief Operating Officer
HRA Pharma Rare Diseases
John Lagus

John Lagus

Managing Director of Business Development
Tanner Pharma Group

John Lagus

Managing Director of Business Development
Tanner Pharma Group
Paula Albuquerque

Paula Albuquerque

PharmD, MBA, MSc
UCB

Paula Albuquerque

PharmD, MBA, MSc
UCB
SPONSORS
Sponsors & Exhibitors
example-image

PRA Health Sciences

PAST EVENT GALLERY